Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1982-04-12
1985-01-29
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 72, 435 76, 435253, A61K 3171, C07H 1708
Patent
active
044965460
ABSTRACT:
Fermentation of a culture of Nocardia sp. ATCC 39043 produces an antibiotic complex comprising erythromycin D, 3",4"-di-O-acetylerythromcyin D, 3"-O-acetyl-4"-O-propionylerythromycin D and 4"-O-acetylerythromycin D. The components are separated and are each useful in vitro and in vivo as antibacterial agents. If erythromycin D is the desired product, the esters can be hydrolyzed prior to the separation of the erythromycin D.
REFERENCES:
patent: 3884903 (1975-05-01), Jones et al.
patent: 4363803 (1982-12-01), Hauske
Majer et al., J. Am. Chem. Soc., 99, pp. 1620-1622, (1977).
Jones et al., J. Med. Chem., 15, pp. 631-634, (1972).
Martin et al., J. Med. Chem., 15, pp. 635-638, (1972).
Bartner et al., J. Chem. Soc., Perkin I, pp. 1600-1624, (1979).
Celmer Walter D.
Cullen Walter P.
Shibakawa Riichiro
Tone Junsuke
Watts Paul C.
Blackwood Robert K.
Brown Johnnie R.
Frost Albert E.
Knuth Charles J.
Peselev Elli
LandOfFree
Erythromycin D and esters thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythromycin D and esters thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythromycin D and esters thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-506117